Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSV | O60911 | 1/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.73 |
| ▸ | CTSS | P25774 | 1/20 | 0.73 |
| ▸ | CTSK | P43235 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25758378 | 1.00 | CTSV (0.73) | CTSVCYP3A4CTSSCTSK | |
| SCHEMBL25757518 | 0.91 | CTSV (0.61) | CTSVCYP3A4CTSSCTSK | |
| SCHEMBL25270645 | 0.91 | CTSV (0.75) | CTSVCYP3A4CTSSCTSK | |
| SCHEMBL25270644 | 0.91 | CTSV (0.75) | CTSVCYP3A4CTSSCTSK | |
| SCHEMBL25758429 | 0.91 | CTSV (0.75) | CTSVCYP3A4CTSSCTSK | |
| SCHEMBL25758361 | 0.90 | — | — | |
| SCHEMBL25757480 | 0.90 | — | — | |
| SCHEMBL25757489 | 0.90 | — | — | |
| SCHEMBL24108849 | 0.89 | CTSV (0.77) | CTSVCYP3A4CTSSCTSK | |
| SCHEMBL27249963 | 0.89 | CTSV (0.77) | CTSVCYP3A4CTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250074938-A1 | CELL-PERMEANT INHIBITORS OF VIRAL CYSTEINE PROTEASES | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2025-03-06 | — | — | US | disclosed |
| US-20230192660-A1 | Protease Inhibitors for Treatment or Prevention of Coronavirus Disease | UNIV LELAND STANFORD JUNIOR (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023114516-A2 | CELL-PERMEANT INHIBITORS OF VIRAL CYSTEINE PROTEASES | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023114516-A2 | CELL-PERMEANT INHIBITORS OF VIRAL CYSTEINE PROTEASES | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2023-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192660-A1 | Protease Inhibitors for Treatment or Prevention of Coronavirus Disease | ACE, ACE2, PEPD | CTSV 43/4885CYP3A4 865/4885CTSS 29/4885 |
| US-20250074938-A1 | CELL-PERMEANT INHIBITORS OF VIRAL CYSTEINE PROTEASES | ACE, TMPRSS2, ACE2 | CTSV 7/4885CYP3A4 1083/4885CTSS 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.